School of Medicine
Showing 1-20 of 22 Results
-
Caleb Lareau
Postdoctoral Research Fellow, Pathology
Bio Postdoctoral research fellow interested in computational biology, single-cell genomics, immunology, and machine learning.
-
Sumin Lee
Postdoctoral Research Fellow, Pathology
Current Research and Scholarly Interests Staphylococcus aureus is a commensal human pathogen that is a major cause of infections worldwide. The new methods for visualizing the site of infection and subsequent response to treatment would greatly improve current clinical management of S. aureus infection.I aim to develop imaging tool to monitor infection in vivo that make use of small molecule activity-based probes (ABPs) that specifically target a family of serine hydrolases enzymes in S. aureus.
-
Tristan Lerbs
Postdoctoral Research Fellow, Pathology
Bio 1997 - 2006: High school, Bonn, Germany
2007 - 2008: Police officer training, Hahn, Germany
2008 - 2015: Medical training, Heidelberg, Germany
2015 - 2016: Resident in General Surgery, Eschweiler, Germany
2016: Resident in Internal Medicine, Aachen, Germany -
Robert Kazimierz Lesniak
Instructor, Pathology
Bio Robert K. Le?niak joined the Medicinal Chemistry Knowledge Center at Stanford ChEM-H in 2018 as a postdoctoral fellow. Prior to coming to Stanford, he worked with Professor Chris Schofield at the University of Oxford, as a postdoctoral research associate, designing novel antibiotics for the European gram-negative antibacterial engine (ENABLE) and UK Medical Research Council (MRC). Dr Le?niak also completed his DPhil under the guidance of Professor Schofield as a BHF-CRE studentship recipient, which involved the design and implementation of small molecules targeting Fe(II), 2-oxoglutarate dependent oxygenase enzymes involved in carnitine biosynthesis and hypoxic response as a means to treat cardiovascular disease. In addition, work on small-molecule modulation of bacterial metallo-beta-lactamases to combat antibiotic resistance was also carried out. Dr Le?niak completed his undergraduate at the University of Bristol, and worked at GlaxoSmithKline, North Carolina, developing inhibitors of bromodomains and histone acetyl-transferases. He is currently working with Professor Thomas Montine at the Stanford School of Medicine on the design of neurotransmitter prodrugs.
-
Joseph (Joe) Lipsick
Professor of Pathology, of Genetics and, by courtesy, of Biology
Current Research and Scholarly Interests Function and evolution of the Myb oncogene family; function and evolution of E2F transcriptional regulators and RB tumor suppressors; epigenetic regulation of chromatin and chromosomes; cancer genetics.
-
Scott Lovell
Postdoctoral Research Fellow, Pathology
Bio Scott received his B.S. in Chemistry from the University of Sheffield in the summer of 2013. As part of his bachelor?s degree he worked for AstraZeneca from Sept 2011 ? Aug 2012 as an organic synthetic chemist. In 2019 he earned his Ph.D. in Chemical Biology from Imperial College London where he worked with Prof. Edward Tate. His thesis focused on developing covalent inhibitors for KLK proteases to decipher their role in prostate cancer progression. Having joined the Bogyo lab in October 2019, Scott now works on developing selective inhibitors and substrates for serine hydrolases in cancer and pathogenic bacteria by using diverse chemical libraries and phage-display approaches.
-
Alarice Cheng-Yi Lowe
Associate Professor of Pathology at the Stanford University Medical Center
Bio Dr. Lowe joined the School of Medicine faculty in 2019. She received her undergraduate degree in Biology from MIT and her medical degree at UCSD, prior to residency and cytology fellowship at UCLA. In 2011, she joined the faculty at Brigham and Women's Hospital where she developed a research focus on Circulating Tumor Cells (CTCs) and the application of CTC technology to improve clinical diagnostics. Clinically, her interests focus on Cytopathology and Genitourinary Pathology.
-
Bingwei Lu
Professor of Pathology
Current Research and Scholarly Interests We are interested in understanding how neural stem cells balance their self-renewal and differentiation and how deregulation of this process can result in brain tumor. We are also interested in mechanisms of neurodegeneration in Alzheimer’s and Parkinson’s diseases. We are using both Drosophila and mammalian models to address these fundamental questions.
-
Katherine L. Lucot
Postdoctoral Research Fellow, Pathology
Bio Katie is interested in translational genomics using animals as models for human diseases, with an emphasis on neurodegenerative diseases and early detection.
